Human Reproduction, Vol. 14, No. 3, 722-725,
March 1999
© 1999 European Society of Human Reproduction and Embryology
A randomized double-blind placebo-controlled study to assess the effect of oral contraceptive pills on the outcome of medical abortion with mifepristone and misoprostol
1 Department of Obstetrics and Gynaecology, The University of Hong Kong, Hong Kong, China and 2 Shanghai Institute of Family Planning Technical Instruction, International Peace Maternity and Child Health Hospital, China Welfare Institute, Shanghai, People's Republic of China
This was a randomized double-blind placebo-controlled trial to determine the effect of oral contraceptive (OC) pills taken immediately after medical abortion on the duration of bleeding and complete abortion rate. Two hundred women in the first 49 days of pregnancy were given 200 mg mifepristone orally followed by 400 µg misoprostol vaginally 48 h later. One day later, they were randomized to receive either OC pills (30 µg of ethinyl oestradiol and 0.15 mg of levonorgestrel per tablet) or placebo for 21 days. The complete abortion rates were 98% in the OC group and 99% in the placebo group. The median duration of bleeding was similar: 17 (range: 5–57) days in the OC group and 16 (range: 6–55) days in the placebo group. In the OC group there was a small but significant fall in the haemoglobin concentration by 14 days (5.3 g/dl) after administration of mifepristone. The incidence of side-effects was similar in the two groups. We conclude that the use of OC pills does not decrease the duration of bleeding after medical abortion nor does it affect the abortion rate.
Key words: mifepristone/misoprostol/oral contraceptive pills/post-abortion bleeding
3 To whom correspondence should be addressed
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  O. S. Tang, S. W.H. Lee, and P. C. Ho A prospective randomized study on the measured blood loss in medical termination of early pregnancy by three different misoprostol regimens after pretreatment with mifepristone Hum. Reprod., November 1, 2002; 17(11): 2865 - 2868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. S. Tang, B.Y. Miao, S. W.H. Lee, and P. C. Ho Pilot study on the use of repeated doses of sublingual misoprostol in termination of pregnancy up to 12 weeks gestation: efficacy and acceptability Hum. Reprod., March 1, 2002; 17(3): 654 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Shan Tang, J. Xu, L. Cheng, S. W.H. Lee, and P. Chung Ho The effect of contraceptive pills on the measured blood loss in medical termination of pregnancy by mifepristone and misoprostol: a randomized placebo controlled trial Hum. Reprod., January 1, 2002; 17(1): 99 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Christin-Maitre, P. Bouchard, and I. M. Spitz Medical Termination of Pregnancy N. Engl. J. Med., March 30, 2000; 342(13): 946 - 956. [Full Text] [PDF]
|
|
|
|
|
|
K.S. Wong, C.S.W. Ngai, E.L.K. Yeo, L.C.H. Tang, and P.C. Ho A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial Hum. Reprod., March 1, 2000; 15(3): 709 - 712. [Abstract] [Full Text] [PDF]
|
|